DenosumabVarious toxicities following off-label treatment: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1781卷 / 1期

关键词：

D O I：

10.1007/s40278-019-71959-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：136 / 136

相关论文

共 50 条

[1] DenosumabVarious toxicities following an off-label use: 4 case reports
[J]. Reactions Weekly, 2020, 1833 (1) : 155 - 155
[2] BuprenorphineVarious toxicities following off-label treatment: 2 case reports
[J]. Reactions Weekly, 2020, 1832 (1) : 81 - 81
[3] Azithromycin/chloroquineVarious toxicities following off-label treatment: 2 case reports
[J]. Reactions Weekly, 2021, 1848 (1) : 83 - 83
[4] DenosumabVarious toxicities and off label use: 4 case reports
[J]. Reactions Weekly, 2023, 1938 (1) : 496 - 496
[5] RituximabVarious toxicities following off-label use: 2 case reports
[J]. Reactions Weekly, 2020, 1834 (1) : 234 - 234
[6] AtropineVarious toxicities following off-label use: 2 case reports
[J]. Reactions Weekly, 2019, 1766 (1) : 66 - 66
[7] Ceftriaxone/ertapenemVarious toxicities following off-label treatment: 4 case reports
[J]. Reactions Weekly, 2019, 1766 (1) : 97 - 97
[8] Multiple drugsCardiac toxicities following off-label treatment: 3 case reports
[J]. Reactions Weekly, 2020, 1823 (1) : 245 - 245
[9] BevacizumabVarious toxicities during off-label treatment: 2 case reports
[J]. Reactions Weekly, 2019, 1772 (1) : 76 - 76
[10] Multiple drugsVarious toxicities following interaction and off-label: 2 case reports
[J]. Reactions Weekly, 2020, 1819 (1) : 196 - 196

← 1 2 3 4 5 →